|
PAPD4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.357610E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.662300E-03 |
| Normal-vs-Stage2 |
3.939200E-03 |
| Normal-vs-Stage3 |
8.575100E-04 |
| Normal-vs-Stage4 |
7.123900E-03 |
| Stage1-vs-Stage2 |
4.053400E-01 |
| Stage1-vs-Stage3 |
3.156800E-01 |
| Stage1-vs-Stage4 |
5.710200E-01 |
| Stage2-vs-Stage3 |
9.283800E-01 |
| Stage2-vs-Stage4 |
8.318400E-01 |
| Stage3-vs-Stage4 |
8.671600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.975170E-03 |
| Normal-vs-AfricanAmerican |
3.606600E-01 |
| Normal-vs-Asian |
1.094400E-02 |
| Caucasian-vs-AfricanAmerican |
2.317600E-01 |
| Caucasian-vs-Asian |
9.343800E-01 |
| AfricanAmerican-vs-Asian |
2.987600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.675700E-03 |
| Normal-vs-Female |
1.361980E-03 |
| Male-vs-Female |
7.381200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.381600E-02 |
| Normal-vs-Age(41-60Yrs) |
7.989300E-04 |
| Normal-vs-Age(61-80Yrs) |
1.464310E-03 |
| Normal-vs-Age(81-100Yrs) |
7.300100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.968200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.419040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.373200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.324200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.414200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.671800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.605400E-01 |
| Classical-VS-Follicular |
5.037100E-03 |
| Classical-VS-Other |
6.898800E-01 |
| Classical-VS-Normal |
2.570300E-02 |
| Tall-VS-Follicular |
6.988800E-01 |
| Tall-VS-Other |
7.578800E-01 |
| Tall-VS-Normal |
5.837700E-03 |
| Follicular-VS-Other |
6.198400E-01 |
| Follicular-VS-Normal |
2.560500E-04 |
| Other-VS-Normal |
1.960250E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.418900E-04 |
| Normal-vs-N1 |
6.275400E-03 |
| N0-vs-N1 |
7.250800E-01 |
|
|
